NCT07258979 2025-12-02
A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2 Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
BeiGene
National Cancer Institute, Naples
Danish Head and Neck Cancer Group
China Medical University Hospital
Daiichi Sankyo
Stanford University
Sun Yat-sen University